本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioNTech SE

87.99
+0.93001.07%
盤後:87.01-0.9800-1.11%19:59 EDT
成交量:87.06萬
成交額:7,629.56萬
市值:221.03億
市盈率:-11.32
高:88.19
開:86.52
低:85.81
收:87.06
52周最高:124.00
52周最低:79.52
股本:2.51億
流通股本:1.09億
量比:0.78
換手率:0.80%
股息:- -
股息率:- -
每股收益(TTM):-7.7726
每股收益(LYR):-5.5184
淨資產收益率:-9.30%
總資產收益率:-5.41%
市淨率:1.12
市盈率(LYR):-15.94

資料載入中...

2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 | BioNTech 大股東 ATHOS KG 擬減持55605股,總價約693萬美元
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 10%股東 ATHOS KG 擬減持50萬股,總價約6170萬美元
2024/09/16

關聯方擬減持公告

Form 144 | BioNTech SE 股東 ATHOS KG 擬減持90000股,總價約1134萬美元
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities